Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Central administration of angiotensin IV rapidly enhances novel object recognition among mice.

Paris JJ, Eans SO, Mizrachi E, Reilley KJ, Ganno ML, McLaughlin JP.

Neuropharmacology. 2013 Jul;70:247-53. doi: 10.1016/j.neuropharm.2013.01.025. Epub 2013 Feb 14.

2.

Blockade of pro-cognitive effects of angiotensin IV and physostigmine in mice by oxytocin antagonism.

Gard PR, Naylor C, Ali S, Partington C.

Eur J Pharmacol. 2012 May 15;683(1-3):155-60. doi: 10.1016/j.ejphar.2012.02.048. Epub 2012 Mar 10.

PMID:
22433837
3.

(+)-UH 232, a partial agonist of the D3 dopamine receptors, attenuates cognitive effects of angiotensin IV and des-Phe(6)-angiotensin IV in rats.

Braszko JJ.

Eur Neuropsychopharmacol. 2010 Apr;20(4):218-25. doi: 10.1016/j.euroneuro.2009.11.012. Epub 2009 Dec 30.

PMID:
20042318
4.
5.

Effect of D(3) dopamine receptors blockade on the cognitive effects of angiotensin IV in rats.

Braszko JJ, Wielgat P, Walesiuk A.

Neuropeptides. 2008 Jun;42(3):301-9. doi: 10.1016/j.npep.2008.02.001. Epub 2008 Mar 24.

PMID:
18359517
6.

Angiotensin IV enhances LTP in rat dentate gyrus in vivo.

Wayner MJ, Armstrong DL, Phelix CF, Wright JW, Harding JW.

Peptides. 2001 Sep;22(9):1403-14.

PMID:
11514021
7.

Dopamine D4 receptor antagonist L745,870 abolishes cognitive effects of intracerebroventricular angiotensin IV and des-Phe(6)-Ang IV in rats.

Braszko JJ.

Eur Neuropsychopharmacol. 2009 Feb;19(2):85-91. doi: 10.1016/j.euroneuro.2008.08.011. Epub 2008 Oct 5.

PMID:
18835699
8.

Cognitive effects attributed to angiotensin II may result from its conversion to angiotensin IV.

Braszko JJ, Walesiuk A, Wielgat P.

J Renin Angiotensin Aldosterone Syst. 2006 Sep;7(3):168-74.

PMID:
17094054
9.

Effect of I.C.V. injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats.

Lee J, Albiston AL, Allen AM, Mendelsohn FA, Ping SE, Barrett GL, Murphy M, Morris MJ, McDowall SG, Chai SY.

Neuroscience. 2004;124(2):341-9.

PMID:
14980384
10.

The object recognition task in rats and mice: a simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity.

Bertaina-Anglade V, Enjuanes E, Morillon D, Drieu la Rochelle C.

J Pharmacol Toxicol Methods. 2006 Sep-Oct;54(2):99-105. Epub 2006 Apr 15.

PMID:
16750402
11.

Involvement of the AT1 receptor subtype in the effects of angiotensin IV and LVV-haemorphin 7 on hippocampal neurotransmitter levels and spatial working memory.

De Bundel D, Demaegdt H, Lahoutte T, Caveliers V, Kersemans K, Ceulemans AG, Vauquelin G, Clinckers R, Vanderheyden P, Michotte Y, Smolders I.

J Neurochem. 2010 Mar;112(5):1223-34. doi: 10.1111/j.1471-4159.2009.06547.x. Epub 2009 Dec 17.

12.

Participation of D 1-4 dopamine receptors in the pro-cognitive effects of angiotensin IV and des-Phe 6 angiotensin IV.

Braszko JJ.

Neurosci Biobehav Rev. 2010 Mar;34(3):343-50. doi: 10.1016/j.neubiorev.2009.08.001. Epub 2009 Aug 15. Review.

PMID:
19686774
13.

Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist.

Krebs LT, Kramár EA, Hanesworth JM, Sardinia MF, Ball AE, Wright JW, Harding JW.

Regul Pept. 1996 Dec 3;67(2):123-30.

PMID:
8958583
14.

Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation.

Beyer CE, Dwyer JM, Platt BJ, Neal S, Luo B, Ling HP, Lin Q, Mark RJ, Rosenzweig-Lipson S, Schechter LE.

Psychopharmacology (Berl). 2010 May;209(4):303-11. doi: 10.1007/s00213-010-1791-1. Epub 2010 Mar 12.

PMID:
20224888
15.

Biological activities of angiotensin II-(1-6)-hexapeptide and angiotensin II-(1-7)-heptapeptide in man.

Kono T, Taniguchi A, Imura H, Oseko F, Khosla MC.

Life Sci. 1986 Apr 21;38(16):1515-9.

PMID:
3702589
16.

Interactions of angiotensin IV and oxytocin on behaviour in mice.

Gard PR, Daw P, Mashhour ZS, Tran P.

J Renin Angiotensin Aldosterone Syst. 2007 Sep;8(3):133-8.

PMID:
17907101
17.

SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.

de Bruin NM, Prickaerts J, Lange JH, Akkerman S, Andriambeloson E, de Haan M, Wijnen J, van Drimmelen M, Hissink E, Heijink L, Kruse CG.

Neurobiol Learn Mem. 2010 May;93(4):522-31. doi: 10.1016/j.nlm.2010.01.010. Epub 2010 Feb 2.

PMID:
20132903
18.

D2 dopamine receptor blockade prevents cognitive effects of Ang IV and des-Phe6 Ang IV.

Braszko JJ.

Physiol Behav. 2006 Jun 15;88(1-2):152-9. Epub 2006 May 11.

PMID:
16690090
19.

Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats.

de Bruin NM, Prickaerts J, van Loevezijn A, Venhorst J, de Groote L, Houba P, Reneerkens O, Akkerman S, Kruse CG.

Neurobiol Learn Mem. 2011 Sep;96(2):392-402. doi: 10.1016/j.nlm.2011.06.015. Epub 2011 Jul 3.

PMID:
21757018
20.

Neuropeptide S enhances memory and mitigates memory impairment induced by MK801, scopolamine or Aβ₁₋₄₂ in mice novel object and object location recognition tasks.

Han RW, Zhang RS, Xu HJ, Chang M, Peng YL, Wang R.

Neuropharmacology. 2013 Jul;70:261-7. doi: 10.1016/j.neuropharm.2013.02.002. Epub 2013 Feb 21.

PMID:
23454528
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk